Zymeworks authorizes $125 million share repurchase program
Zymeworks Inc. (NASDAQ: ZYME) announced that its board of directors authorized a new share repurchase program allowing the company to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
